• Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Localized or Locally Advanced Prostate Cancer Eligible for Surgery

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany

  • Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium France Germany Hungary Italy Poland +2

  • Study on Optimizing Treatment for Chronic Heart Failure with Reduced Ejection Fraction Using Nebivolol and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study on Reducing Rituximab Dosage for Patients with Rheumatoid Arthritis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Hungary Italy Poland Spain

  • Study on Dapagliflozin to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on Zilucoplan Sodium for Children Aged 2 to 17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland

  • Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain

  • Study on the Effect of Botulinum Toxin Type A and Physiological NaCl 0.9% in Patients with Piriformis Syndrome

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

powered by